메뉴 건너뛰기




Volumn 25, Issue 2, 2013, Pages 209-215

Complement disorders and hemolytic uremic syndrome

Author keywords

Factor H; Factor I; Membrane cofactor protein; Plasma exchange

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C2A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; ECULIZUMAB; MEMBRANE COFACTOR PROTEIN; THROMBOMODULIN;

EID: 84875382274     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32835df48a     Document Type: Review
Times cited : (37)

References (46)
  • 1
    • 73849090193 scopus 로고    scopus 로고
    • Complement and its role in innate and adaptive immune responses
    • Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res 2010; 20:34-50.
    • (2010) Cell Res , vol.20 , pp. 34-50
    • Dunkelberger, J.R.1    Song, W.C.2
  • 2
    • 0035810399 scopus 로고    scopus 로고
    • Complement. First of two parts
    • Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344:1058-1066.
    • (2001) N Engl J Med , vol.344 , pp. 1058-1066
    • Walport, M.J.1
  • 3
    • 70349437186 scopus 로고    scopus 로고
    • Complement regulators and inhibitory proteins
    • Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009; 9:729-740.
    • (2009) Nat Rev Immunol , vol.9 , pp. 729-740
    • Zipfel, P.F.1    Skerka, C.2
  • 4
    • 77955883153 scopus 로고    scopus 로고
    • Complement: A key system for immune surveillance and homeostasis
    • Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: A key system for immune surveillance and homeostasis. Nat Immunol 2010; 11:785-797.
    • (2010) Nat Immunol , vol.11 , pp. 785-797
    • Ricklin, D.1    Hajishengallis, G.2    Yang, K.3    Lambris, J.D.4
  • 5
    • 33645569820 scopus 로고    scopus 로고
    • Membrane cofactor protein and factor I: Mutations and transplantation
    • Kavanagh D, Goodship TH. Membrane cofactor protein and factor I: Mutations and transplantation. Semin Thromb Hemost 2006; 32:155-159.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 155-159
    • Kavanagh, D.1    Goodship, T.H.2
  • 6
    • 84855278759 scopus 로고    scopus 로고
    • Complement-mediated injury and protection of endothelium: Lessons from atypical haemolytic uraemic syndrome
    • Kerr H, Richards A. Complement-mediated injury and protection of endothelium: Lessons from atypical haemolytic uraemic syndrome. Immunobiology 2012; 217:195-203.
    • (2012) Immunobiology , vol.217 , pp. 195-203
    • Kerr, H.1    Richards, A.2
  • 8
    • 33747159590 scopus 로고    scopus 로고
    • Genetics of HUS: The impact of MCP CFH, and IF mutations on clinical presentation, response to treatment, and outcome
    • Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: The impact of MCP CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108:1267-1279.
    • (2006) Blood , vol.108 , pp. 1267-1279
    • Caprioli, J.1    Noris, M.2    Brioschi, S.3
  • 10
    • 53749084348 scopus 로고    scopus 로고
    • Complement and the atypical hemolytic uremic syndrome in children
    • Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008; 23:1957-1972.
    • (2008) Pediatr Nephrol , vol.23 , pp. 1957-1972
    • Loirat, C.1    Noris, M.2    Fremeaux-Bacchi, V.3
  • 12
    • 27844566613 scopus 로고    scopus 로고
    • Atypical haemolytic uraemic syndrome and mutations in complement regulator genes
    • Springer
    • Dragon-Durey MA, Fremeaux-Bacchi V. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 2005; 27:359-374.
    • (2005) Semin Immunopathol , vol.27 , pp. 359-374
    • Dragon-Durey, M.A.1    Fremeaux-Bacchi, V.2
  • 13
    • 0031970553 scopus 로고    scopus 로고
    • Genetic studies into inherited and sporadic hemolytic uremic syndrome
    • Warwicker P, Goodship TH, Donne RL, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998; 53:836-844.
    • (1998) Kidney Int , vol.53 , pp. 836-844
    • Warwicker, P.1    Goodship, T.H.2    Donne, R.L.3
  • 14
    • 0019387503 scopus 로고
    • Hypocomplementaemia due to a genetic deficiency of beta 1H globulin
    • Thompson RA, Winterborn MH. Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. Clin Exp Immunol 1981; 46:110-119.
    • (1981) Clin Exp Immunol , vol.46 , pp. 110-119
    • Thompson, R.A.1    Winterborn, M.H.2
  • 15
    • 20544437666 scopus 로고    scopus 로고
    • Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome
    • Dragon-Durey MA, Loirat C, Cloarec S, et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:555-563.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 555-563
    • Dragon-Durey, M.A.1    Loirat, C.2    Cloarec, S.3
  • 16
    • 70350279315 scopus 로고    scopus 로고
    • Atypical hemolytic-uremic syndrome
    • Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361:1676-1687.
    • (2009) N Engl J Med , vol.361 , pp. 1676-1687
    • Noris, M.1    Remuzzi, G.2
  • 17
    • 78649863686 scopus 로고    scopus 로고
    • Clinical features of antifactor H autoantibody-associated hemolytic uremic syndrome
    • Dragon-Durey MA, Sethi SK, Bagga A, et al. Clinical features of antifactor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol 2010; 21:2180-2187.
    • (2010) J Am Soc Nephrol , vol.21 , pp. 2180-2187
    • Dragon-Durey, M.A.1    Sethi, S.K.2    Bagga, A.3
  • 18
    • 75649133611 scopus 로고    scopus 로고
    • Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI CD46, and C3 in patients with atypical hemolytic uremic syndrome
    • Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 2010; 115:379-387.
    • (2010) Blood , vol.115 , pp. 379-387
    • Moore, I.1    Strain, L.2    Pappworth, I.3
  • 19
    • 0242331610 scopus 로고    scopus 로고
    • Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome
    • Richards A, Kemp EJ, Liszewski MK, et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2003; 100:12966-12971.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 12966-12971
    • Richards, A.1    Kemp, E.J.2    Liszewski, M.K.3
  • 20
    • 77958587405 scopus 로고    scopus 로고
    • Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
    • Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5:1844-1859.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 1844-1859
    • Noris, M.1    Caprioli, J.2    Bresin, E.3
  • 21
    • 19444369542 scopus 로고    scopus 로고
    • Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome
    • Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, et al. Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004; 41:e84.
    • (2004) J Med Genet , vol.41
    • Fremeaux-Bacchi, V.1    Dragon-Durey, M.A.2    Blouin, J.3
  • 22
    • 34547633064 scopus 로고    scopus 로고
    • Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome
    • Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007; 18:2392-2400.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2392-2400
    • Sellier-Leclerc, A.L.1    Fremeaux-Bacchi, V.2    Dragon-Durey, M.A.3
  • 23
    • 67651166873 scopus 로고    scopus 로고
    • Thrombomodulin mutations in atypical hemolytic-uremic syndrome
    • Delvaeye M, Noris M, De VA, et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361:345-357.
    • (2009) N Engl J Med , vol.361 , pp. 345-357
    • Delvaeye, M.1    Noris, M.2    De, V.A.3
  • 24
    • 54049137505 scopus 로고    scopus 로고
    • Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
    • Fremeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008; 112:4948-4952.
    • (2008) Blood , vol.112 , pp. 4948-4952
    • Fremeaux-Bacchi, V.1    Miller, E.C.2    Liszewski, M.K.3
  • 25
    • 84860711841 scopus 로고    scopus 로고
    • A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
    • Roumenina LT, Frimat M, Miller EC, et al. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 2012; 119:4182-4191.
    • (2012) Blood , vol.119 , pp. 4182-4191
    • Roumenina, L.T.1    Frimat, M.2    Miller, E.C.3
  • 26
    • 33846094404 scopus 로고    scopus 로고
    • Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
    • Goicoechea de JE, Harris CL, Esparza-Gordillo J, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2007; 104:240-245.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 240-245
    • Goicoechea De, J.E.1    Harris, C.L.2    Esparza-Gordillo, J.3
  • 27
  • 28
    • 84863985862 scopus 로고    scopus 로고
    • Atypical hemolytic uremic syndrome in children: Complement mutations and clinical characteristics
    • Geerdink LM, Westra D, van Wijk JA, et al. Atypical hemolytic uremic syndrome in children: Complement mutations and clinical characteristics. Pediatr Nephrol 2012; 27:1283-1291.
    • (2012) Pediatr Nephrol , vol.27 , pp. 1283-1291
    • Geerdink, L.M.1    Westra, D.2    Van Wijk, J.A.3
  • 29
    • 84858776139 scopus 로고    scopus 로고
    • Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations
    • Kavanagh D, Goodship TH. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations. Hematology Am Soc Hematol Educ Program 2011; 2011:15-20.
    • (2011) Hematology Am Soc Hematol Educ Program , vol.2011 , pp. 15-20
    • Kavanagh, D.1    Goodship, T.H.2
  • 30
    • 61549117207 scopus 로고    scopus 로고
    • Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
    • Ariceta G, Besbas N, Johnson S, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009; 24:687-696.
    • (2009) Pediatr Nephrol , vol.24 , pp. 687-696
    • Ariceta, G.1    Besbas, N.2    Johnson, S.3
  • 32
    • 77957587756 scopus 로고    scopus 로고
    • Treatment of typical (enteropathic) hemolytic uremic syndrome
    • Bitzan M, Schaefer F, Reymond D. Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36:594-610.
    • (2010) Semin Thromb Hemost , vol.36 , pp. 594-610
    • Bitzan, M.1    Schaefer, F.2    Reymond, D.3
  • 33
    • 44449165673 scopus 로고    scopus 로고
    • Successful pretransplant management of a patient with antifactor H autoantibodies-associated haemolytic uraemic syndrome
    • Kwon T, Dragon-Durey MA, Macher MA, et al. Successful pretransplant management of a patient with antifactor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol Dial Transplant 2008; 23:2088-2090.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 2088-2090
    • Kwon, T.1    Dragon-Durey, M.A.2    Macher, M.A.3
  • 34
    • 77951621575 scopus 로고    scopus 로고
    • Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anticomplement factor H autoantibodies
    • Boyer O, Balzamo E, Charbit M, et al. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anticomplement factor H autoantibodies. Am J Kidney Dis 2010; 55:923-927.
    • (2010) Am J Kidney Dis , vol.55 , pp. 923-927
    • Boyer, O.1    Balzamo, E.2    Charbit, M.3
  • 35
    • 62449341861 scopus 로고    scopus 로고
    • Autoantibodies in haemolytic uraemic syndrome (HUS)
    • Skerka C, Jozsi M, Zipfel PF, et al. Autoantibodies in haemolytic uraemic syndrome (HUS). Thromb Haemost 2009; 101:227-232.
    • (2009) Thromb Haemost , vol.101 , pp. 227-232
    • Skerka, C.1    Jozsi, M.2    Zipfel, P.F.3
  • 36
    • 79151471122 scopus 로고    scopus 로고
    • AHUS caused by complement dysregulation: New therapies on the horizon
    • Waters AM, Licht C. aHUS caused by complement dysregulation: New therapies on the horizon. Pediatr Nephrol 2011; 26:41-57.
    • (2011) Pediatr Nephrol , vol.26 , pp. 41-57
    • Waters, A.M.1    Licht, C.2
  • 37
    • 59449107473 scopus 로고    scopus 로고
    • Eculizumab for atypical hemolyticuremic syndrome
    • Nurnberger J, Philipp T, Witzke O, et al. Eculizumab for atypical hemolyticuremic syndrome. N Engl J Med 2009; 360:542-544.
    • (2009) N Engl J Med , vol.360 , pp. 542-544
    • Nurnberger, J.1    Philipp, T.2    Witzke, O.3
  • 38
    • 70349907791 scopus 로고    scopus 로고
    • Complement inhibitor eculizumab in atypical hemolytic uremic syndrome
    • Mache CJ, Acham-Roschitz B, Fremeaux-Bacchi V, et al. Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4:1312-1316.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 1312-1316
    • Mache, C.J.1    Acham-Roschitz, B.2    Fremeaux-Bacchi, V.3
  • 39
    • 58249107188 scopus 로고    scopus 로고
    • Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient
    • Chan MR, Thomas CP, Torrealba JR, et al. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am J Kidney Dis 2009; 53:321-326.
    • (2009) Am J Kidney Dis , vol.53 , pp. 321-326
    • Chan, M.R.1    Thomas, C.P.2    Torrealba, J.R.3
  • 40
    • 79954443076 scopus 로고    scopus 로고
    • Eculizumab induces long-term remission in recurrent posttransplant HUS associated with C3 gene mutation
    • Al-Akash SI, Almond PS, Savell VH Jr, et al. Eculizumab induces long-term remission in recurrent posttransplant HUS associated with C3 gene mutation. Pediatr Nephrol 2011; 26:613-619.
    • (2011) Pediatr Nephrol , vol.26 , pp. 613-619
    • Al-Akash, S.I.1    Almond, P.S.2    Savell Jr., V.H.3
  • 41
    • 79958202220 scopus 로고    scopus 로고
    • Preemptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome
    • Nester C, Stewart Z, Myers D, et al. Preemptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2011; 6:1488-1494.
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 1488-1494
    • Nester, C.1    Stewart, Z.2    Myers, D.3
  • 42
    • 80052473232 scopus 로고    scopus 로고
    • Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome
    • Weitz M, Amon O, Bassler D, et al. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 2011; 26:1325-1329.
    • (2011) Pediatr Nephrol , vol.26 , pp. 1325-1329
    • Weitz, M.1    Amon, O.2    Bassler, D.3
  • 43
    • 77951876953 scopus 로고    scopus 로고
    • Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome
    • Zimmerhackl LB, Hofer J, Cortina G, et al. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med 2010; 362:1746-1748.
    • (2010) N Engl J Med , vol.362 , pp. 1746-1748
    • Zimmerhackl, L.B.1    Hofer, J.2    Cortina, G.3
  • 44
    • 65649106258 scopus 로고    scopus 로고
    • Liver-kidney transplantation to cure atypical hemolytic uremic syndrome
    • Saland JM, Ruggenenti P, Remuzzi G. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 2009; 20:940-949.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 940-949
    • Saland, J.M.1    Ruggenenti, P.2    Remuzzi, G.3
  • 45
    • 64049101602 scopus 로고    scopus 로고
    • Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome
    • Saland JM, Shneider BL, Bromberg JS, et al. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4:201-206.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 201-206
    • Saland, J.M.1    Shneider, B.L.2    Bromberg, J.S.3
  • 46
    • 37549018997 scopus 로고    scopus 로고
    • Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H
    • Jalanko H, Peltonen S, Koskinen A, et al. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 2008; 8:216-221.
    • (2008) Am J Transplant , vol.8 , pp. 216-221
    • Jalanko, H.1    Peltonen, S.2    Koskinen, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.